Showing results (381-390 of 609) with videos related to
Sort By:
Pageof 61
European Urology Focus|July 24, 2024
Readability Assessment of Patient Education Materials on Uro-oncological Diseases Using Automated MeasuresSeverin Rodler, Serena Maruccia, Andre Abreu, et al.Cancer Biology & Therapy|September 6, 2007
Preclinical and clinical studies with the multi-kinase inhibitor CEP-701 as treatment for prostate cancer demonstrate the inadequacy of PSA response as a primary endpointConnie Collins, Michael A Carducci, Mario A Eisenberger, et al.Urology|March 31, 2010
Long-term survival after radical prostatectomy for men with high Gleason sum in pathologic specimenPhillip M Pierorazio, Thomas J Guzzo, Misop Han, et al.The Journal of Urology|December 6, 2016
Implementation of a Surgeon-Level Comparative Quality Performance Review to Improve Positive Surgical Margin Rates during Radical ProstatectomyRichard S Matulewicz, Jeffrey J Tosoian, C J Stimson, et al.The Journal of Urology|February 16, 2005
Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason gradeAlexander Haese, Ville Vaisanen, Hans Lilja, et al.The Journal of Urology|February 28, 2009
Prostate specific antigen testing among the elderly--when to stop?Edward M Schaeffer, H Ballentine Carter, Anna Kettermann, et al.Cancer|October 22, 2008
Biochemical recurrence after radical prostatectomy for prevalent versus incident cases of prostate cancer : implications for managementPaul L Nguyen, Ming-Hui Chen, William J Catalona, et al.JAMA Network Open|July 26, 2024
Readability and Information Quality in Cancer Information From a Free vs Paid ChatbotDavid Musheyev, Alexander Pan, Preston Gross, et al.The Journal of Urology|February 14, 2006
Pathological characteristics of prostate cancer detected through prostate specific antigen based screeningStacy Loeb, Chris M Gonzalez, Kimberly A Roehl, et al.BJU International|April 10, 2014
Genetically adjusted prostate-specific antigen values may prevent delayed biopsies in African-American menNicholas M Donin, Stacy Loeb, Phillip R Cooper, et al.Pageof 61